THRIVENT FINANCIAL FOR LUTHERANS – Halozyme Therapeutics, Inc. Transaction History
THRIVENT FINANCIAL FOR LUTHERANS portfolio value:
$52.10M
portfolio value
THRIVENT FINANCIAL FOR LUTHERANS quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.63% | -8.32K shares | -6.24M | $39.54 | 1.31M |
| Q2 2022 | share | Decrease | -9.61% | -140.91K shares | -156K | $44 | 1.32M |
| Q1 2022 | share | Increase | +36.23% | 390.13K shares | 15.20M | $39.88 | 1.46M |
| Q4 2021 | share | Increase | +42.96% | 323.58K shares | 12.65M | $40.32 | 1.07M |
| Q3 2021 | share | Decrease | -1.88% | -14.46K shares | -4.22M | $40.68 | 753.24K |
| Q2 2021 | share | Increase | +4.60% | 33.73K shares | 4.26M | $45.41 | 767.70K |
| Q1 2021 | share | Decrease | -41.12% | -512.63K shares | -22.64M | $41.69 | 733.97K |
| Q4 2020 | share | Increase | +4.78% | 56.81K shares | 21.97M | $42.71 | 1.24M |
| Q3 2020 | share | Increase | +0.88% | 10.42K shares | -351K | $26.28 | 1.18M |
| Q2 2020 | share | Increase | +0.44% | 5.17K shares | 10.49M | $26.81 | 1.17M |
| Q1 2020 | share | Decrease | -0.27% | -3.23K shares | 248K | $17.99 | 1.17M |
| Q4 2019 | share | Decrease | -69.54% | -2.68M shares | -39.08M | $17.73 | 1.17M |
| Q3 2019 | share | Increase | +2.11% | 80.05K shares | -5.08M | $15.51 | 3.86M |
| Q2 2019 | share | Increase | +3.16% | 115.83K shares | 5.95M | $17.18 | 3.78M |
| Q1 2019 | share | Increase | +3.01% | 107.32K shares | 6.96M | $16.1 | 3.66M |
| Q4 2018 | share | Increase | +13.61% | 426.77K shares | -4.85M | $14.63 | 3.56M |
| Q3 2018 | share | Increase | +35.39% | 819.59K shares | 17.90M | $18.17 | 3.13M |
| Q2 2018 | share | Increase | 0.00% | 2.31M shares | 39.07M | $16.87 | 2.31M |